We have put together a handbook of exclusive information on some of the most pertinent issues facing the sector. This handbooks draws on the discussions of leading experts and real-life experiences shared at the 2018 Pharma Contract Manufacturing conference, and will serve as a guide to navigating the challenges of Pharma/CMO relationships and best practises for building long-lasting strategic partnerships for the future.
We spoke exclusively with Luiz Barberini, Sr. Operations Manager - External Manufacturing Latin America, Bayer about how he manages relationships with contract manufacturers.
From this discussion we have put together this handy pocket guide which covers topics including conflict management, mitigating risks and building resourceful and lasting relationships with contractors.
Nowadays, nearly 80% of drugs currently FDA approved on behalf of small bio/pharma companies are contract manufactured, and 50% of products supported by mid-size companies use a CMO. In the lead up to the Pharma Contract Manufacturing Conference, Pharma IQ have looked at the evolution of the roles of CMOs and CDMOs in the industry, and what the future will bring for these organisations.
When building a resourceful and reliable relationship with a CMO it is critical that both companies understand each other’s culture, mission and values. Pharma IQ caught up with Christophe Stevens, Associate Director External Manufacturing, UCB and Christophe Defrance, External Manufacturing Director, UCB to discuss the optimisation and consolidation of their extensive CMO network.